$0.08
-0.01 (-8.89%)
Neose Technologies, Inc. (NTEC)
CAPS Rating:
A clinical stage biopharmaceutical company focused on the development of next-generation therapeutic proteins.
A clinical stage biopharmaceutical company focused on the development of next-generation therapeutic proteins.